AAAAAA

   
Results: 1-10 |
Results: 10
INCREASED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND COAGULATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: LEURS PB VANOERLE R WOLFFENBUTTEL BHR HAMULYAK K
Citation: Pb. Leurs et al., INCREASED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND COAGULATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS, Thrombosis and haemostasis, 77(3), 1997, pp. 472-476
HYPERINSULINEMIA AND FIBRINOLYSIS IN THE ELDERLY
Authors: STOLK RP LEURS PB WOLFFENBUTTEL BHR GROBBEE DE
Citation: Rp. Stolk et al., HYPERINSULINEMIA AND FIBRINOLYSIS IN THE ELDERLY, Diabetologia, 39, 1996, pp. 246-246
INCREASED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) ACTIVITY AND COAGULATION IN IDDM PATIENTS
Authors: LEURS PB VANOERLE R WOLFFENBUTTEL BHR HAMULYAK K
Citation: Pb. Leurs et al., INCREASED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) ACTIVITY AND COAGULATION IN IDDM PATIENTS, Diabetologia, 39, 1996, pp. 898-898
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN NORMAL, IGT, AND NIDDM SUBJECTS
Authors: WOLFFENBUTTEL BHR STOLK RP VANOERLE R HAMULYAK K GROBBEE DE LEURS PB
Citation: Bhr. Wolffenbuttel et al., TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN NORMAL, IGT, AND NIDDM SUBJECTS, Diabetologia, 39, 1996, pp. 899-899
D-GLUCOSE INCREASES TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE FROM CULTURED ENDOTHELIAL-CELLS (EC) AFTER HEPARIN STIMULATION
Authors: LEURS PB VANOERLE R WOLFFENBUTTEL BHR HAMULYAK K
Citation: Pb. Leurs et al., D-GLUCOSE INCREASES TISSUE FACTOR PATHWAY INHIBITOR (TFPI) RELEASE FROM CULTURED ENDOTHELIAL-CELLS (EC) AFTER HEPARIN STIMULATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1261-1261
HEPARIN-INDUCED RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) FROM HUMAN ENDOTHELIAL HYBRID-CELLS
Authors: VANOERLE R LEURS PB LINDHOUT T HAMULYAK K
Citation: R. Vanoerle et al., HEPARIN-INDUCED RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) FROM HUMAN ENDOTHELIAL HYBRID-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 1262-1262
TISSUE FACTOR PATHWAY INHIBITOR IN IDDM PATIENTS WITH AND WITHOUT MICROVASCULAR AND OR MACROVASCULAR COMPLICATIONS/
Authors: LEURS PB VANOERLE R HAMULYAK K WOLFFENBUTTEL BHR
Citation: Pb. Leurs et al., TISSUE FACTOR PATHWAY INHIBITOR IN IDDM PATIENTS WITH AND WITHOUT MICROVASCULAR AND OR MACROVASCULAR COMPLICATIONS/, Diabetologia, 38, 1995, pp. 53-53
TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY IN PATIENTS WITH IDDM
Authors: LEURS PB VANOERLE R HAMULYAK K WOLFFENBUTTEL BHR
Citation: Pb. Leurs et al., TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY IN PATIENTS WITH IDDM, Diabetes, 44(1), 1995, pp. 80-84
IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS
Authors: WOLFFENBUTTEL BHR LEURS PB SELS JPJE RONDASCOLBERS GJWM MENHEERE PPCA KRUSEMAN ACN
Citation: Bhr. Wolffenbuttel et al., IMPROVED BLOOD-GLUCOSE CONTROL BY INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS HAS NO EFFECT ON LIPOPROTEIN(A) LEVELS, Diabetic medicine, 10(5), 1993, pp. 427-430
LIPOPROTEIN(A) LEVELS IN RELATION TO DIABETIC COMPLICATIONS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES
Authors: HEESEN BJ WOLFFENBUTTEL BHR LEURS PB SELS JPJE MENHEERE PPCA JACKLEBECKERS SEC KRUSEMAN ACN
Citation: Bj. Heesen et al., LIPOPROTEIN(A) LEVELS IN RELATION TO DIABETIC COMPLICATIONS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES, European journal of clinical investigation, 23(9), 1993, pp. 580-584
Risultati: 1-10 |